US Patent 11957686 Compositions for delivery of reboxetine
Patent 11957686 was granted and assigned to axsome therapeutics, inc. on April, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 17 Apr, 2024
Golden AI
Edits made to:
Infobox (+37 properties)
Article (+344 characters)
US Patent 11957686 Compositions for delivery of reboxetine
Article
Patent abstract
Described herein are methods for the administration of reboxetine, or a pharmaceutically acceptable salt thereof, to a human being in need thereof, resulting in a first maximum plasma concentration and a second maximum plasma concentration, wherein the two maxima are separated by a time period of about 2 hours to about 6 hours.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Herriot Tabuteau0
Date of Patent
April 16, 2024
0Patent Application Number
178486850
Date Filed
June 24, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11957686 Compositions for delivery of reboxetine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
